Catalyst Event
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
From Akros SCHK HK-Korea Momentum Factor Index (ASHKMOM)
6/4/2026, 12:00:00 AM
Announced board approval for FX hedging up to USD 150 million; routine risk management is estimated to have a >1% price impact.
Korean Translation
최대 1억 5천만 달러 규모의 외환 헤지 사업 수행에 대한 이사회 승인을 발표하였으며, 이는 1% 이상의 주가 영향이 예상되는 조치임.
Related Recent Events
Sun Hung Kai Properties Ltd (16) · Earnings Release
Full year results for fiscal year 2026 scheduled.
9/3/2026, 12:00:00 AM
SK Hynix Inc (000660) · Earnings Release
SK Hynix is scheduled to release its Q2 2026 earnings results on July 29, 2026; medium importance justified by expected >5% price impact from quarterly performance scheduled.
7/29/2026, 12:00:00 AM
Samsung Electronics Co Ltd (005930) · Earnings Release
Importance is estimated as the event is in the future. Q2 2026 earnings release scheduled.
7/23/2026, 12:00:00 AM
COSCO SHIPPING Energy Transportation Co. Ltd. (1138) · Other
Ex-dividend date for the 2025 final dividend of HKD 0.43007 per share on 2026-07-17; market analysts justify medium impact due to dividend payout; event scheduled.
7/17/2026, 12:00:00 AM
Sinotruk (Hong Kong) Ltd (3808) · Other
Ex-dividend date for the HK$0.88 per share final dividend for the year ended December 31, 2025, is scheduled for July 9, 2026; low importance as a routine technical adjustment is scheduled.
7/9/2026, 12:00:00 AM
Yangtze Optical Fibre And Cable Joint Stock Ltd Co (6869) · Other
Ex-dividend date of 2026-07-03 for a proposed final dividend of RMB 0.295 per share for the year ended Dec 31, 2025, with payment on 2026-08-21 following approval on 2026-06-30; the dividend is expected to have a price impact of at least 1% scheduled
7/3/2026, 12:00:00 AM